Trump's FDA Pick Overton Dodges Senate Questions on Vaccines — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Heidi Overton, a preventive medicine physician from rural New Mexico who served in the White House during both Trump terms, sat before the Senate committee that will decide whether her nomination advances to a full Senate vote.
- Overton was questioned on hot-button issues including childhood vaccines, the abortion drug mifepristone, and China, but revealed little of her own positions, instead repeatedly citing existing FDA guidance and current product approvals.
- Overton declined to say whether she would update that guidance or alter approvals to align with the priorities of Trump or Health Secretary Robert F. Kennedy Jr.
- Sen. Chris Murphy (D-Conn.) directly observed during his questioning that Overton had 'done a pretty good job of avoiding answering questions so far.'
Why it matters: The FDA commissioner role directly governs approvals for vaccines and abortion drugs — two of the most contested policy areas in Trump's second term — and Overton's refusal to preview how she would handle pressure from Trump and RFK Jr. leaves senators and the public without a clear signal on whether she will reshape existing guidance or preserve it.
Ask SkimNews
